Argenx Se (ARGX) Finished Goods (2021 - 2024)
Argenx Se (ARGX) posted quarterly Finished Goods of $38.4 million for Q2 2024, up 31.64% year-on-year from $29.2 million in Q3 2023, and up 69.66% on a QoQ basis from $22.6 million in Q4 2023.
Argenx Se (ARGX) Finished Goods (2021 - 2024) Analysis & Trends
Argenx Se (ARGX) has reported Finished Goods for 4 consecutive years, with $38.4 million the latest figure, recorded in Q2 2024.
- Quarterly Finished Goods rose 31.64% year-over-year to $38.4 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $38.4 million (up 31.64% YoY) and the FY2023 annual result came in at $22.6 million, down 39.29% from the prior year.
- Finished Goods improved to $38.4 million in Q2 2024 per ARGX's latest filing, from $22.6 million in the prior quarter.
- Over the last five years, Finished Goods for ARGX reached as high as $38.4 million in Q2 2024 and fell as low as $1.2 million in Q4 2021.
- A 4-year average of $24.9 million and a median of $25.9 million in 2023 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2022 — Finished Goods surged 2914.63% — and 2023, when it plunged 39.29%.
- Year by year, Finished Goods stood at $1.2 million in 2021, then jumped by 2914.63% to $37.3 million in 2022, then tumbled by 39.29% to $22.6 million in 2023, then jumped by 69.66% to $38.4 million in 2024.
- According to Business Quant data, Finished Goods over the past three periods registered $38.4 million, $22.6 million, and $29.2 million for Q2 2024, Q4 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 38.41 Mn |
| Dec 31, 2023 | 22.64 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Dec 31, 2022 | 37.29 Mn |
| Jun 30, 2022 | 20.91 Mn |
| Dec 31, 2021 | 1.24 Mn |